Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03168100
Title 2017-03: A Single-Arm, Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 (Anti-SLAMF7) Monoclonal Antibody (mAb) Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Arkansas
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field